Importer of Controlled Substances Notice of Application, 21298-21299 [E7-8133]

Download as PDF 21298 Federal Register / Vol. 72, No. 82 / Monday, April 30, 2007 / Notices mockery of judicial power.’’ SBC Commc’ns, at *14. In 2004, Congress amended the APPA to ensure that courts take into account the above-quoted list of relevant factors when making a public interest determination. Compare 15 U.S.C. 16(e) (2004) with 15 U.S.C. 16(e)(1) (2006) (substituting ‘‘shall’’ for ‘‘may’’ in directing relevant factors for court to consider and amending list of factors to focus on competitive considerations and to address potentially ambiguous judgment terms). These amendments, however, did not change the fundamental role of courts in reviewing proposed settlements. To the contrary, Congress made clear its intent to preserve the practical benefits of utilizing consent decrees in antitrust enforcement, adding the unambiguous instruction ‘‘[n]othing in this section shall be construed to require the court to conduct an evidentiary hearing or to require the court to permit anyone to intervene.’’ 15 U.S.C. 16 (e)(2). This language codified the intent of the original 1974 statute, expressed by Senator Tunney in the legislative history: ‘‘[t]he court is nowhere compelled to go to trial or to engage in extended proceedings which might have the effect of vitiating the benefits of prompt and less costly settlement through the consent decree process.’’ 119 Cong. Rec. 24,598 (1973) (statement of Senator Tunney). Rather: rwilkins on PROD1PC63 with NOTICES [a]bsent a showing of corrupt failure of the government to discharge its duty, the Court, in making its public interest finding, should . . . carefully consider the explanations of the government in the competitive impact statement and its responses to comments in order to determine whether those explanations are reasonable under the circumstances. United States v. Mid-America Dairymen, Inc., 1977–1 Trade Cas. (CCH) ¶ 61,508, at 71,980 (W.D. Mo. 1977). This-Court recently examined the role of the district court in reviewing proposed final judgments in light of the 2004 amendments, confirming that the amendments ‘‘effected minimal changes[] and that this Court’s scope of review remains sharply proscribed by precedent and the nature of Tunney Act proceedings.’’ See United States v. SBC Commc’ns, Inc., Nos. 05–2102 and 05–2103, 2007 WL 1020746, at *9 (D.D.C. Mar. 29, 2007). This Court concluded that the amendments did not alter the articulation of the public interest standard in Microsoft. Id. at *15. VIII. Determinative Documents There are no determinative materials or documents within the meaning of the APPA that were considered by the United States in formulating the proposed Final Judgment. Dated: April 18, 2007. Respectfully submitted, VerDate Aug<31>2005 18:27 Apr 27, 2007 Jkt 211001 /s/ lllllllllllllllll C. Scott Hataway Bar No. 473942, U.S. Department of Justice, Antitrust Division, Lit II Section, 1401 H Street NW., Washington, DC 20530 202–514– 8380. [FR Doc. 07–2087 Filed 4–27–07; 8:45am] BILLING CODE 4410–11–M DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances Notice of Application This is notice that on October 18, 2006, Noramco Inc., 500 Swedes Landing Road, Wilmington, Delaware 19801, made application by renewal to the Drug Enforcement Administration (DEA) for registration as an importer of the basic classes of controlled substances listed in schedule II: Drug Schedule Raw Opium (9600) ....................... Concentrate of Poppy Straw (9670). II II The company plans to import the listed controlled substances to manufacture other controlled substances. As noted in a previous notice published in the Federal Register on September 23, 1975, (40 FR 43745), all applicants for registration to import a basic class of any controlled substances in schedule I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1301.34(b), (c), (d), (e) and (f) are satisfied. Dated: April 17, 2007. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control Drug Enforcement Administration. [FR Doc. E7–8132 Filed 4–27–07; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances Notice of Application Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on March 1, 2007, Organichem Corporation, 33 Riverside PO 00000 Frm 00097 Fmt 4703 Sfmt 4703 Avenue, Rensselaer, New York 12144, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Oxymorphone (9652), a basic class of controlled substance listed in schedule II. The company plans on manufacturing the listed controlled substance in bulk for sale to its customers. Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Attention: DEA Federal Register Representative (ODL), Washington, DC 20537, or any being sent via express mail should be sent to Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed no later than June 29, 2007. Dated: April 17, 2007. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control Drug Enforcement Administration. [FR Doc. E7–8131 Filed 4–27–07; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances Notice of Application This is notice that on January 26, 2007, Stepan Company, Natural Products Department, 100 W. Hunter Avenue, Maywood, New Jersey 07607, made application by renewal to the Drug Enforcement Administration (DEA) for registration as an importer of Coca Leaves (9040), a basic class of controlled substance listed in schedule II. The company plans to import the listed controlled substance for the manufacture of a bulk controlled substance for distribution to its customer. As noted in a previous notice published in the Federal Register on September 23, 1975, (40 FR 43745), all applicants for registration to import a basic class of any controlled substances in schedule I or II are, and will continue to be, required to demonstrate to the E:\FR\FM\30APN1.SGM 30APN1 Federal Register / Vol. 72, No. 82 / Monday, April 30, 2007 / Notices Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1301.34(b), (c), (d), (e) and (f) are satisfied. Dated: April 17, 2007. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control Drug Enforcement Administration. [FR Doc. E7–8133 Filed 4–27–07; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF LABOR Office of the Secretary Submission for OMB Review: Comment Request rwilkins on PROD1PC63 with NOTICES April 24, 2007. The Department of Labor (DOL) has submitted the following public information collection requests (ICR) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995 (Pub. L. 104–13, 44 U.S.C. chapter 35). A copy of each ICR, with applicable supporting documentation, may be obtained from RegInfo.gov at https://www.reginfo.gov/ public/do/PRAMain or by contacting Darrin King on 202–693–4129 (this is not a toll-free number) / e-mail: king.darrin@dol.gov. Comments should be sent to Office of Information and Regulatory Affairs, Attn: OMB Desk Officer for the Occupational Safety and Health Administration (OSHA), Office of Management and Budget, Room 10235, Washington, DC 20503, Telephone: 202–395–7316/Fax: 202–395–6974 (these are not a toll-free numbers), within 30 days from the date of this publication in the Federal Register. The OMB is particularly interested in comments which: • Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; • Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; • Enhance the quality, utility, and clarity of the information to be collected; and • Minimize the burden of the collection of information on those who are to respond, including through the VerDate Aug<31>2005 18:27 Apr 27, 2007 Jkt 211001 use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Agency: Occupational Safety and Health Administration. Type of Review: Extension without change of currently approved collection. Title: Access to Employee Exposure and Medical Records (29 CFR 1910.1020). OMB Number: 1218–0065. Type of Response: Recordkeeping. Affected Public: Public Sector: Business or other for-profits. Number of Respondents: 734,820. Number of Annual Responses: 6,503,968. Estimated Time per Response: Varies by task. Total Burden Hours: 720,187. Total Annualized capital/startup costs: $0. Total Annual Costs (operating/ maintaining systems or purchasing services): $0. Description: The Standard requires employers to preserve and provide access to records associated with employees’ exposure to toxic chemicals and harmful physical agents. Employee records and access to them are critically important to the detection, treatment, and prevention of occupational illness and disease. Agency: Occupational Safety and Health Administration. Type of Review: Extension without change of currently approved collection. Title: Formaldehyde (1910.1048). OMB Number: 1218–0145. Type of Response: Recordkeeping and Third-party disclosure. Affected Public: Public Sector: Business or other for-profits. Number of Respondents: 112,638. Number of Annual Responses: 1,903,049. Estimated Time per Response: Varies by task. Total Burden Hours: 519,076. Total Annualized capital/startup costs: $0. Total Annual Costs (operating/ maintaining systems or purchasing services): $55,325,688. Description: The Formaldehyde Standard and its collections of information are designed to provide protection for employees from the adverse health effects associated with occupational exposure to formaldehyde. The Standard requires employers to monitor employee exposure and provide notification to employees of their exposure. Employers are required to PO 00000 Frm 00098 Fmt 4703 Sfmt 4703 21299 make available medical surveillance to employees. Agency: Occupational Safety and Health Administration. Type of Review: Extension without change of currently approved collection. Title: Definition and Requirements for a Nationally Recognized Testing Laboratory (29 CFR 1910.7). OMB Number: 1218–0147. Type of Response: Reporting. Affected Public: Public Sector: Business or other for-profits. Number of Respondents: 67. Number of Annual Responses: 67. Estimated Time per Response: 20 hours. Total Burden Hours: 1,340. Total Annualized capital/startup costs: $0. Total Annual Costs (operating/ maintaining systems or purchasing services): $0. Description: A number of OSHA’s standards require certain equipment to be ‘‘tested’’ (or ‘‘approved’’) by a ‘‘nationally recognized testing laboratory’’ (NRTL). An organization seeking to perform this testing (or approval) must be ‘‘recognized’’ by OSHA and must apply to the OSHA NRTL Program for recognition. Recognition is granted after OSHA determines that the organization meets certain requirements. Darrin A. King, Acting Departmental Clearance Officer. [FR Doc. E7–8142 Filed 4–27–07; 8:45 am] BILLING CODE 4510–26–P DEPARTMENT OF LABOR Employee Benefits Security Administration [Prohibited Transaction Exemption 2007– 06; Exemption Application Nos. D–11383, L–11384, D–11385, D–11383, L–11384, D– 11385, L–11302 and L–11303] Grant of Individual Exemptions Involving; Kern County Electrical Pension Trust (the Pension Plan), Kern County Electrical Joint Apprenticeship and Training Trust (the Apprenticeship Plan), Kern County Electrical Health and Welfare Plan (the Welfare Plan), The International Brotherhood of Electrical Workers Local Union 428 (the Local Union), OPET Health Care and Life Insurance Plans RM3A and RM5A (Together, the HYL Plans), and OPET Prescription Drug Plan RRx (Plan RRx; All Three Together, the Plans) Employee Benefits Security Administration, Labor. AGENCY: E:\FR\FM\30APN1.SGM 30APN1

Agencies

[Federal Register Volume 72, Number 82 (Monday, April 30, 2007)]
[Notices]
[Pages 21298-21299]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-8133]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances Notice of Application

    This is notice that on January 26, 2007, Stepan Company, Natural 
Products Department, 100 W. Hunter Avenue, Maywood, New Jersey 07607, 
made application by renewal to the Drug Enforcement Administration 
(DEA) for registration as an importer of Coca Leaves (9040), a basic 
class of controlled substance listed in schedule II.
    The company plans to import the listed controlled substance for the 
manufacture of a bulk controlled substance for distribution to its 
customer.
    As noted in a previous notice published in the Federal Register on 
September 23, 1975, (40 FR 43745), all applicants for registration to 
import a basic class of any controlled substances in schedule I or II 
are, and will continue to be, required to demonstrate to the

[[Page 21299]]

Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration, that the requirements for such registration 
pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1301.34(b), 
(c), (d), (e) and (f) are satisfied.

    Dated: April 17, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control Drug 
Enforcement Administration.
 [FR Doc. E7-8133 Filed 4-27-07; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.